EE158 Budget Impact of LYBALVI® for the Treatment of Schizophrenia and Bipolar I Disorder from a US Payer Perspective
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.407
https://www.valueinhealthjournal.com/article/S1098-3015(22)00608-8/fulltext
Title :
EE158 Budget Impact of LYBALVI® for the Treatment of Schizophrenia and Bipolar I Disorder from a US Payer Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00608-8&doi=10.1016/j.jval.2022.04.407
First page :
Section Title :
Open access? :
No
Section Order :
10360